In this interview, they discuss the role of direct oral anticoagulants (DOAC) as a treatment for cancer-associated thrombosis (CAT), including updates to the guidelines and the importance of patient-centric care. A discussion of key unmet needs as described by the two experts and a look to the future of anticoagulation in patients with cancer is also included.
EMJ Oncology [Supplement 3] . 2022
February 2022
In this issue
Latest articles
All articles![](https://www.emjreviews.com/wp-content/uploads/2024/04/Onc-Aparna-Parikh-Interview-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2024/03/TN-1-1-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2024/02/Eugena-Stamuli-thumbnail-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/02/GSK-ONC-010-23-2-Thumbnail-940x564.png)